Skip to main content
SpringerLink
Log in

Lyphmknotenmetastasen bei unbekanntem Primärtumor

  • Chapter
  • First Online:
Pathologie

  • 3604 Accesses

Zusammenfassung

Lymphknotenmetastasen sind eine häufige Ursache für die Durchführung von Lymphknotenbiopsien. Dieses Kapitel behandelt die Strategien für die Abklärung des sog. CUP(carcinoma of unknown primary)-Syndroms. Klinische Befunde und Lymphknotenlokalisation begründen den Einsatz einer differentiellen immunhistochemischen und molekularen Diagnostik, wobei in der Differenzialdiagnostik auch die Abgrenzung zu entzündlich überlagerten Lymphomen und nicht epithelialen Tumoren bedeutsam ist.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 389.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 499.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  1. Blaustein’s Pathology of the Female Genital Tract (2011) Springer, New York

    Google Scholar 

  2. Quick Reference Handbook for Surgical Pathologists (2011) Springer, New York

    Google Scholar 

  3. Agaimy A, Erlenbach-Wunsch K, Konukiewitz B et al (2013) ISL1 expression is not restricted to pancreatic well-differentiated neuroendocrine neoplasms, but is also commonly found in well and poorly differentiated neuroendocrine neoplasms of extrapancreatic origin. Mod Pathol 26:995–1003

    Article  CAS  PubMed  Google Scholar 

  4. Agoff SN, Lamps LW, Philip AT et al (2000) Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors. Mod Pathol 13:238–242

    Article  CAS  PubMed  Google Scholar 

  5. Barr ML, Jilaveanu LB, Camp RL et al (2015) PAX-8 expression in renal tumours and distant sites: a useful marker of primary and metastatic renal cell carcinoma? J Clin Pathol 68:12–17

    Article  PubMed  Google Scholar 

  6. Bellizzi AM (2013) Assigning site of origin in metastatic neuroendocrine neoplasms: a clinically significant application of diagnostic immunohistochemistry. Adv Anat Pathol 20:285–314

    Article  CAS  PubMed  Google Scholar 

  7. Brewster DH, Lang J, Bhatti LA et al (2014) Descriptive epidemiology of cancer of unknown primary site in Scotland, 1961–2010. Cancer Epidemiol 38:227–234

    Article  PubMed  Google Scholar 

  8. Byrd-Gloster AL, Khoor A, Glass LF et al (2000) Differential expression of thyroid transcription factor 1 in small cell lung carcinoma and Merkel cell tumor. Hum Pathol 31:58–62

    Article  CAS  PubMed  Google Scholar 

  9. Chen ZE, Lin F (2015) Application of immunohistochemistry in gastrointestinal and liver neoplasms: new markers and evolving practice. Arch Pathol Lab Med 139:14–23

    Article  PubMed  Google Scholar 

  10. Chu PG, Weiss LM (2002) Keratin expression in human tissues and neoplasms. Histopathology 40:403–439

    Article  CAS  PubMed  Google Scholar 

  11. Conner JR, Hornick JL (2015) Metastatic carcinoma of unknown primary: diagnostic approach using immunohistochemistry. Adv Anat Pathol 22:149–167

    Article  CAS  PubMed  Google Scholar 

  12. Curtin JA, Fridlyand J, Kageshita T et al (2005) Distinct sets of genetic alterations in melanoma. N Engl J Med 353:2135–2147

    Article  CAS  PubMed  Google Scholar 

  13. Egberts F, Bergner I, Krüger S et al (2014) Metastatic melanoma of unknown primary resembles the genotype of cutaneous melanomas. Ann Oncol 25:246–250

    Article  CAS  PubMed  Google Scholar 

  14. Egberts F, Krüger S, Behrens HM et al (2014) Melanomas of unknown primary frequently harbor TERT-promoter mutations. Melanoma Res 24:131–136

    Article  CAS  PubMed  Google Scholar 

  15. Fizazi K, Greco FA, Pavlidis N et al (2015) Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-updagger. Ann Oncol 26(Suppl 5):v133–v138

    Article  PubMed  Google Scholar 

  16. Greco FA, Lennington WJ, Spigel DR, Hainsworth JD (2013) Molecular profiling diagnosis in unknown primary cancer: accuracy and ability to complement standard pathology. J Natl Cancer Inst 105:782–790

    Article  CAS  PubMed  Google Scholar 

  17. Hainsworth JD, Greco FA (2014) Gene expression profiling in patients with carcinoma of unknown primary site: from translational research to standard of care. Virchows Arch 464:393–402

    Article  CAS  PubMed  Google Scholar 

  18. Hainsworth JD, Rubin MS, Spigel DR et al (2013) Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon research institute. J Clin Oncol 31:217–223

    Article  CAS  PubMed  Google Scholar 

  19. Klöppel G (2015) Neoplasien des disseminierten neuroendokrine Zellsystems des Gastrointestinaltrakts. Pathologe 36:237–245

    Article  PubMed  Google Scholar 

  20. Köbel M, Bak J, Bertelsen BI et al (2014) Ovarian carcinoma histotype determination is highly reproducible, and is improved through the use of immunohistochemistry. Histopathology 64:1004–1013

    Article  PubMed  Google Scholar 

  21. Koo J, Zhou X, Moschiano E et al (2013) The immunohistochemical expression of islet 1 and PAX8 by rectal neuroendocrine tumors should be taken into account in the differential diagnosis of metastatic neuroendocrine tumors of unknown primary origin. Endocr Pathol 24:184–190

    Article  CAS  PubMed  Google Scholar 

  22. Liu H, Shi J, Wilkerson ML, Lin F (2012) Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas. Am J Clin Pathol 138:57–64

    Article  PubMed  Google Scholar 

  23. Miettinen M, McCue PA, Sarlomo-Rikala M et al (2014) GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors. Am J Surg Pathol 38:13–22

    Article  PubMed Central  PubMed  Google Scholar 

  24. Moll R, Divo M, Langbein L (2008) The human keratins: biology and pathology. Histochem Cell Biol 129:705–733

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Ordonez NG (2012) Value of PAX 8 immunostaining in tumor diagnosis: a review and update. Adv Anat Pathol 19:140–151

    Article  CAS  PubMed  Google Scholar 

  26. Pavlidis N, Briasoulis E, Hainsworth J, Greco FA (2003) Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer 39:1990–2005

    Article  CAS  PubMed  Google Scholar 

  27. Pavlidis N, Fizazi K (2009) Carcinoma of unknown primary (CUP). Crit Rev Oncol Hematol 69:271–278

    Article  PubMed  Google Scholar 

  28. Pavlidis N, Pentheroudakis G (2012) Cancer of unknown primary site. Lancet 379:1428–1435

    Article  PubMed  Google Scholar 

  29. Saad RS, Ghorab Z, Khalifa MA, Xu M (2011) CDX2 as a marker for intestinal differentiation: Its utility and limitations. World J Gastrointest Surg 3:159–166

    Article  PubMed Central  PubMed  Google Scholar 

  30. Tetzlaff MT, Torres-Cabala CA, Pattanaprichakul P et al (2015) Emerging clinical applications of selected biomarkers in melanoma. Clin Cosmet Investig Dermatol 8:35–46

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Yamaguchi T, Hosono Y, Yanagisawa K, Takahashi T (2013) NKX2-1/TTF-1: an enigmatic oncogene that functions as a double-edged sword for cancer cell survival and progression. Cancer Cell 23:718–723

    Article  CAS  PubMed  Google Scholar 

  32. Yao JC, Hassan M, Phan A et al (2008) One hundred years after „carcinoid“: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26:3063–3072

    Article  PubMed  Google Scholar 

  33. Zheng R, Blobel GA (2010) GATA transcription factors and cancer. Genes Cancer 1:1178–1188

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Direktor des Instituts für Pathologie, Universitätsklinikum Schleswig-Holstein, Christian-Albrechts-Universität Kiel, Kiel, Deutschland

    Prof. Dr. Christoph Röcken

Authors
  1. Prof. Dr. Christoph Röcken
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christoph Röcken .

Editor information

Editors and Affiliations

  1. der Universität Würzburg, Pathologisches Institut der Universität Würzburg, Würzburg, Bayern, Germany

    Hans Konrad Müller-Hermelink

  2. Medizinische Hochschule Hannover (MHH) Inst. Pathologie, Hannover, Germany

    Hans H. Kreipe

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Röcken, C. (2019). Lyphmknotenmetastasen bei unbekanntem Primärtumor. In: Müller-Hermelink, H., Kreipe, H. (eds) Pathologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-85184-4_29

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-85184-4_29

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-85183-7

  • Online ISBN: 978-3-540-85184-4

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation